Publications by authors named "Jerry Clarin"

Claim this Profile
A
ABBV-184: A Novel Survivin-specific TCR/CD3 Bispecific T-cell Engager is Active against Both Solid Tumor and Hematologic Malignancies.
Adam S Chervin, Jennifer D Stone, Iwona Konieczna, Kelly M Calabrese, Ningyan Wang, Jerry D Clarin

Mol Cancer Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clearance of systemic hematologic tumors by venetoclax (Abt-199) and navitoclax.
Scott Ackler, Anatol Oleksijew, Jun Chen, Brenda J Chyla, Jerry Clarin

Pharmacol Res Perspect· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis